Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans

Diane Stadler, James F. Bale, Catherine A. Chenard, Charles J. Rebouche

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

To elucidate the etiology of valproic acid-induced carnitine deficiency, we tested the hypothesis that long-term valproic acid administration decreases the rate of carnitine reabsorption. Thirteen healthy men participated in a 34-day protocol in which carnitine clearance was measured before and after 28 days of valproic acid administration. During valproic acid administration (days 6 to 33), plasma free and total carnitine concentrations decreased (18% and 12%, respectively, P <.05) by 16 days, but returned to pretreatment concentrations by 28 days. From day 14 to day 30, the rate of free carnitine excretion was 50% lower than at baseline (day 4, P <.05). Free and total carnitine clearance, indexed to the glomerular filtration rate, was lower after valproic acid administration (P <.01). Contrary to our hypothesis, after 28 days of valproic acid administration, the rate of carnitine reabsorption was enhanced independent of the glomerular filtration rate and filtered load. Changes in the plasma concentration, rate of excretion, and clearance were specific for carnitine and were not generalized in magnitude or direction to the other amino acids. We conclude that the kidney adapts to conserve carnitine during valproic acid administration and therefore does not cause valproic acid-induced carnitine depletion in adults.

Original languageEnglish (US)
Pages (from-to)74-79
Number of pages6
JournalMetabolism: Clinical and Experimental
Volume48
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Carnitine
Valproic Acid
Glomerular Filtration Rate
Kidney
Amino Acids

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans. / Stadler, Diane; Bale, James F.; Chenard, Catherine A.; Rebouche, Charles J.

In: Metabolism: Clinical and Experimental, Vol. 48, No. 1, 1999, p. 74-79.

Research output: Contribution to journalArticle

Stadler, Diane ; Bale, James F. ; Chenard, Catherine A. ; Rebouche, Charles J. / Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans. In: Metabolism: Clinical and Experimental. 1999 ; Vol. 48, No. 1. pp. 74-79.
@article{b2b39873510b425795883cfe09a669b0,
title = "Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans",
abstract = "To elucidate the etiology of valproic acid-induced carnitine deficiency, we tested the hypothesis that long-term valproic acid administration decreases the rate of carnitine reabsorption. Thirteen healthy men participated in a 34-day protocol in which carnitine clearance was measured before and after 28 days of valproic acid administration. During valproic acid administration (days 6 to 33), plasma free and total carnitine concentrations decreased (18{\%} and 12{\%}, respectively, P <.05) by 16 days, but returned to pretreatment concentrations by 28 days. From day 14 to day 30, the rate of free carnitine excretion was 50{\%} lower than at baseline (day 4, P <.05). Free and total carnitine clearance, indexed to the glomerular filtration rate, was lower after valproic acid administration (P <.01). Contrary to our hypothesis, after 28 days of valproic acid administration, the rate of carnitine reabsorption was enhanced independent of the glomerular filtration rate and filtered load. Changes in the plasma concentration, rate of excretion, and clearance were specific for carnitine and were not generalized in magnitude or direction to the other amino acids. We conclude that the kidney adapts to conserve carnitine during valproic acid administration and therefore does not cause valproic acid-induced carnitine depletion in adults.",
author = "Diane Stadler and Bale, {James F.} and Chenard, {Catherine A.} and Rebouche, {Charles J.}",
year = "1999",
doi = "10.1016/S0026-0495(99)90013-6",
language = "English (US)",
volume = "48",
pages = "74--79",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans

AU - Stadler, Diane

AU - Bale, James F.

AU - Chenard, Catherine A.

AU - Rebouche, Charles J.

PY - 1999

Y1 - 1999

N2 - To elucidate the etiology of valproic acid-induced carnitine deficiency, we tested the hypothesis that long-term valproic acid administration decreases the rate of carnitine reabsorption. Thirteen healthy men participated in a 34-day protocol in which carnitine clearance was measured before and after 28 days of valproic acid administration. During valproic acid administration (days 6 to 33), plasma free and total carnitine concentrations decreased (18% and 12%, respectively, P <.05) by 16 days, but returned to pretreatment concentrations by 28 days. From day 14 to day 30, the rate of free carnitine excretion was 50% lower than at baseline (day 4, P <.05). Free and total carnitine clearance, indexed to the glomerular filtration rate, was lower after valproic acid administration (P <.01). Contrary to our hypothesis, after 28 days of valproic acid administration, the rate of carnitine reabsorption was enhanced independent of the glomerular filtration rate and filtered load. Changes in the plasma concentration, rate of excretion, and clearance were specific for carnitine and were not generalized in magnitude or direction to the other amino acids. We conclude that the kidney adapts to conserve carnitine during valproic acid administration and therefore does not cause valproic acid-induced carnitine depletion in adults.

AB - To elucidate the etiology of valproic acid-induced carnitine deficiency, we tested the hypothesis that long-term valproic acid administration decreases the rate of carnitine reabsorption. Thirteen healthy men participated in a 34-day protocol in which carnitine clearance was measured before and after 28 days of valproic acid administration. During valproic acid administration (days 6 to 33), plasma free and total carnitine concentrations decreased (18% and 12%, respectively, P <.05) by 16 days, but returned to pretreatment concentrations by 28 days. From day 14 to day 30, the rate of free carnitine excretion was 50% lower than at baseline (day 4, P <.05). Free and total carnitine clearance, indexed to the glomerular filtration rate, was lower after valproic acid administration (P <.01). Contrary to our hypothesis, after 28 days of valproic acid administration, the rate of carnitine reabsorption was enhanced independent of the glomerular filtration rate and filtered load. Changes in the plasma concentration, rate of excretion, and clearance were specific for carnitine and were not generalized in magnitude or direction to the other amino acids. We conclude that the kidney adapts to conserve carnitine during valproic acid administration and therefore does not cause valproic acid-induced carnitine depletion in adults.

UR - http://www.scopus.com/inward/record.url?scp=0032899195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032899195&partnerID=8YFLogxK

U2 - 10.1016/S0026-0495(99)90013-6

DO - 10.1016/S0026-0495(99)90013-6

M3 - Article

VL - 48

SP - 74

EP - 79

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 1

ER -